Home/Filings/4/0001209191-22-002690
4//SEC Filing

Pearce Catherine 4

Accession 0001209191-22-002690

CIK 0001868734other

Filed

Jan 9, 7:00 PM ET

Accepted

Jan 10, 4:19 PM ET

Size

5.5 KB

Accession

0001209191-22-002690

Insider Transaction Report

Form 4
Period: 2022-01-06
Pearce Catherine
Chief Operating Officer
Transactions
  • Award

    Restricted Stock Units

    2022-01-06+26,47126,471 total
    Common Stock (26,471 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock.
  • [F2]The RSUs vest in two equal annual installments beginning January 11, 2023, subject to the continued service by the Reporting Person to the Issuer as of the applicable vesting date.

Issuer

CinCor Pharma, Inc.

CIK 0001868734

Entity typeother

Related Parties

1
  • filerCIK 0001898815

Filing Metadata

Form type
4
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:19 PM ET
Size
5.5 KB